Publication | Closed Access

Increased survival and reversion of iron-induced cardiac disease in patients with thalassemia major receiving intensive combined chelation therapy as compared to desferoxamine alone

Chelation TherapyThrombosisHeart FailureCardiovascular DiseaseIron-induced Cardiac DiseaseHematologyPharmacotherapyCardiovascular ToxicityMedicineCardiologyReperfusion InjuryMyocardial Infarction